Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Our proprietary nicotinamide (NAM) technology leverages the properties of NAM to enhance and expand cells, creating allogeneic cell therapy products and candidates that are potentially curative for patients with hematologic malignancies. Omisirge® (omidubicel-onlv), a nicotinamide modified allogeneic hematopoietic progenitor cell therapy was approved by the US FDA for the treatment of hematologic malignancies.
Brands: https://events.jspargo.com/ASH20/CUSTOM/gamidacellbanner.png